Mechanisms of acantholysis in Pemphigus vulgaris: Role of IgG valence

Clinical Immunology and Immunopathology

Volumn 85, Issue 1, 1997, Pages 90-96

  Mascaró Jr , José M ^a   España, Agustín ^a   Liu, Zhi ^a   Ding, Xiang ^a   Swartz, Sue J ^a   Fairley, Janet A ^a,b   Diaz, Luis A ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DESMOGLEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G;

ACANTHOLYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CROSS LINKING; HUMAN; MOUSE; NONHUMAN; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN;

EID: 0031260365     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4408     Document Type: Article

References (36)

1. Beutner E. H., Jordon R. E. Demonstration of skin antibodies in sera of patients with pemphigus vulgaris by indirect immunofluorescent staining. Proc. Soc. Exp. Biol. Med. 117:1964;505-510.
2. Korman N. J. Pemphigus. J. Am. Acad. Dermatol. 18:1988;1219-1238.
3. Stanley J. R. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv. Immunol. 53:1993;291-325.
4. Karpati S., Amagai M., Prussick R., Cehrs K., Stanley J. R. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is located within keratinocyte desmosomes. J. Cell. Biol. 122:1993;409-415.
5. Amagai M., Klaus-Kovtun V., Stanley J. R. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 67:1991;869-877.
6. Buxton R. S., Cowin P., Franke W. W., Garrod D. R., Green K. J., King I. A., Koch P. J., Magee A. I., Rees D. A., Stanley J. R., Steinberg M. S. Nomenclature of the desmosomal cadherins. J. Cell. Biol. 121:1993;481-483.
7. Eyre R. W., Stanley J. R. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J. Clin. Invest. 81:1988;807-812.
8. Emery D. J., Diaz L. A., Fairley J. A., Lopez A., Taylor A. F., Giudice G. J. Detection and characterization of pemphigus foliaceus autoantibodies that react with the desmoglein-1 ectodomain. J. Invest. Dermatol. 104:1995;323-328.
9. Amagai M., Koch P. J., Nishikawa T., Stanley J. R. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J. Invest. Dermatol. 106:1996;351-355.
10. Anhalt G. J., Labib R. S., Voorhees J. J., Beals T. F., Diaz L. A. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N. Engl. J. Med. 306:1982;1189-1196.
11. Anhalt G. J., Diaz L. A. In vivo studies of antibody dependent acantholysis. Immune Mechanisms in Cutaneous Disease. 1989;Dekker, New York. p. 291-316.
12. Rock B., Labib R. S., Diaz L. A. Monovalent Fab′ immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal BALB/c mice. J. Clin. Invest. 85:1990;296-299.
13. Giudice G. J., Emery D. J., Zelickson B. D., Anhalt G. J., Liu Z., Diaz L. A. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J. Immunol. 151:1993;5742-5750.
14. Amagai M., Hashimoto T., Shimizu N., Nishikawa T. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J. Clin. Invest. 94:1994;59-67.
15. Olague-Alcala M., Giudice G. J., Diaz L. A. Pemphigus foliaceus sera recognize an N-Terminal fragment of bovine desmoglein 1. J. Invest. Dermatol. 102:1994;882-885.
16. Mage M. G. Preparation of Fab fragments from IgGs of different animal species. Methods Enzymol. 70:1980;142-150.
17. Anhalt G. J., Till G. O., Diaz L. A., Labib R. S., Patel H. P., Eaglstein N. F. Defining the role of complement in experimental pemphigus vulgaris in mice. J. Immunol. 137:1986;2835-2840.
18. Rock B., Martins C. R., Theofilopoulos A. N., Balderas R. S., Anhalt G. J., Labib R. S., Futamura S., Rivitti E. A., Diaz L. A. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N. Engl. J. Med. 320:1989;1463-1469.
19. Liu Z., Diaz L. A., Troy J. L., Taylor A. F., Emery D. J., Fairley J. A., Till G. O., Giudice G. J. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J. Clin. Invest. 92:1993;2480-2488.
20. Takahashi Y., Patel H. P., Labib R. S., Diaz L. A., Anhalt G. J. Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: A time-course study of clinical immunologic, ultrastructural, and cytochemical changes. J. Invest. Dermatol. 84:1985;41-46.
21. Amagai M., Karpat I. S., Prussick R., Klaus-kovtun V., Stanley J. R. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J. Clin. Invest. 90:1992;919-926.
22. Memar O. M., Rajaraman S., Thotakura R., Tyring S. K., Fan J. L., Seetharamaiah G. S., Lopez A., Jordon R. E., Prabhakar B. S. Recombinant desmoglein 3 has the necessary epitopes to absorb and induce blister-causing antibodies. J. Invest. Dermatol. 106:1996;261-268.
23. Memar O. M., Christensen B., Rajaraman S., Goldblum R., Tyring S. K., Brysk M. M., McCormick D. J., El Zaim H., Fan J. L., Prabhakar B. S. Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3). J. Immunol. 157:1996;3171-3177.
24. Smith T. W., Lloyd B. L., Spicer N., Haber E. Immunology and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon. Clin. Exp. Immunol. 36:1979;384-396.
25. Spiegelberg H. L., Weigle W. O. The catabolism of homologous and heterologous 7S gamma globulin fragments. J. Exp. Med. 121:1965;323-338.
26. Wochner R. D., Strober W., Waldmann T. A. The role of the kidney in the catabolism of Bence-Jones proteins and immunoglobulin fragments. J. Exp. Med. 126:1967;207-221.
27. Diaz L. A., Marcelo C. L. Pemphigoid and pemphigus antigens in cultured epidermal cells. B. J. Dermatol. 98:1978;631-637.
28. Hashimoto K., Shafran K. M., Webber P. S., Lazarus G. S., Singer H. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J. Exp. Med. 157:1983;259-272.
29. Spillman D. H., Magnin P. H., Roquel L., Mitsui M. Aprotinin inhibition of experimental pemphigus in Balb-c mice following passive transfer of pemphigus foliaceus serum. Clin. Exp. Dermatol. 13:1988;321-327.
30. Naito K., Morioka S., Nakajima S., Ogawa H. Proteinase inhibitors block formation of pemphigus acantholysis in experimental models of neonatal mouse skin explants: Effects of synthetic and plasma proteinase inhibitors on pemphigus. J. Invest. Dermatol. 93:1989;173-177.
31. Jordon R. E. Complement activation in pemphigus. J. Invest. Dermatol. 74:1980;357-359.
32. Hashimoto T., Sugiura M., Kurihara S., Nishikawa T., Hatano H. Experimental acantholysis by complement-fixing intercellular antibodies. Arch. Dermatol. Res. 273:1982;129-135.
33. Seishima M., Esaki C., Osada K., Mori S., Hashimoto T., Kitajima Y. Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. J. Invest. Dermatol. 104:1995;33-37.
34. Esaki C., Seishima M., Yamada T., Osada K., Kitajima Y. Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-triphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. J. Invest. Dermatol. 105:1995;329-333.
35. España A., Diaz L. A., Mascaró J. M. Jr., Giudice G. J., Fairley J. A., Till G. O., Liu Z. Mechanisms of acantholysis in pemphigus foliaceus. Clin. Immunol. Immunopathol. 85:1997;83-89.
36. Koch P. J., Mahoney M., Pulkkinen L., Whitaker-Menezes D., Ishikawa H., Shultz L., Murphy G. F., Uitto J., Stanley J. R. Mice with a targeted gene disruption of pemphigus vulgaris (PV) antigen (desmoglein 3, Dsg3) have a phenotype similar to PV patients. J. Invest. Dermatol. 108:1997;544.